Molnupiravir To Reach 105 LMICs Through MPP Agreement
Almost 30 Generics Manufacturers Will Be Producing Low-Cost Versions Of The Antiviral
Almost 30 generics firms based across 11 countries have signed up to agreements with the Medicines Patent Pool to facilitate the supply of oral COVID-19 treatment molnupiravir to 105 low- and-middle-income countries. The move follows an agreement signed in October by the MPP with Merck.
